11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional … - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …
the ADA's current clinical practice recommendations and is intended to provide the …
Chronic kidney disease
Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …
mortality that occurs commonly in the general adult population, especially in people with …
Diabetic kidney disease
The kidney is arguably the most important target of microvascular damage in diabetes. A
substantial proportion of individuals with diabetes will develop kidney disease owing to their …
substantial proportion of individuals with diabetes will develop kidney disease owing to their …
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2024
Diabetes Care, 2024 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial
Importance Steroidal mineralocorticoid receptor antagonists, when added to a renin-
angiotensin system blocker, further reduce proteinuria in patients with chronic kidney …
angiotensin system blocker, further reduce proteinuria in patients with chronic kidney …
7th Brazilian Guideline of Arterial Hypertension: Presentation
MVB Malachias - Arquivos brasileiros de cardiologia, 2016 - SciELO Brasil
On behalf of the Brazilian Society of Cardiology, Brazilian Society of Hypertension and
Brazilian Society of Nephrology, I present to you the 7th Brazilian Guideline of Arterial …
Brazilian Society of Nephrology, I present to you the 7th Brazilian Guideline of Arterial …
Design and baseline characteristics of the finerenone in reducing kidney failure and disease progression in diabetic kidney disease trial
Background: Among diabetics, those with kidney disease have exceptionally high rates of
cardiovascular (CV) morbidity and mortality, and progression of their underlying disease …
cardiovascular (CV) morbidity and mortality, and progression of their underlying disease …
Aldosterone in chronic kidney disease and renal outcomes
Aims Randomized controlled trials have demonstrated the efficacy of mineralocorticoid
receptor (MR) antagonism in delaying chronic kidney disease (CKD) progression in …
receptor (MR) antagonism in delaying chronic kidney disease (CKD) progression in …
Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups …
R Eschalier, JJV McMurray, K Swedberg… - Journal of the American …, 2013 - jacc.org
Objectives: The study sought to investigate the safety and efficacy of eplerenone in patients
at high risk for hyperkalemia or worsening renal function (WRF) in EMPHASIS-HF, a trial that …
at high risk for hyperkalemia or worsening renal function (WRF) in EMPHASIS-HF, a trial that …